Barosense
Redwood City
About Barosense
BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.6M
- Funding stage: M&A
- Last round: Series D (Aug 2009)
- Website: barosense.com
- Phone: 650-362-6000
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/barosense-3009197 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.